A functional medicine practice in the Mountain West had built a solid GLP-1 program: experienced prescriber, pharmacy partnerships, structured lifestyle coaching, and a clear clinical protocol. They tried to launch Google Ads. Their campaigns were disapproved within 48 hours.
The reason: advertising prescription medications on Google requires LegitScript certification. Without it, Google will not run ads for practices prescribing GLP-1 medications, regardless of how legitimate the practice is or how compliant the program. The practice had built everything correctly except the one prerequisite that determines whether Google Ads is even available to them.
After obtaining LegitScript certification, they rebuilt their account with three campaigns targeting different intent levels: medication-specific terms, weight loss program terms, and telehealth access terms. Cost per qualified lead settled at $68. Consultation-to-enrollment rate: 38 percent.
This is the Google Ads structure for GLP-1 practices that actually works, starting with the compliance requirement that most practices overlook until their ads are already disapproved.
Google Ads for GLP-1 Practices: The LegitScript Requirement
LegitScript is a third-party certification service that verifies healthcare providers and pharmacies are operating legally and in compliance with applicable regulations. Google requires LegitScript certification for any advertiser running ads related to prescription drug programs, including GLP-1 medications like semaglutide and tirzepatide.
The process is not fast. LegitScript certification for a telehealth or clinical practice typically takes four to eight weeks from application submission to approval. Practices that want to advertise on Google must account for this timeline before launching a patient acquisition push.
What LegitScript requires from GLP-1 practices:
State licensing documentation. Proof that the prescribing provider is licensed in each state where patients will be enrolled. Telehealth practices serving multiple states need documentation for each.
Pharmacy partner agreements. Documentation of the pharmacy or pharmacies fulfilling GLP-1 prescriptions. Compounding pharmacies add complexity here, as LegitScript applies additional scrutiny to compounded medication advertising.
Program documentation. Description of the clinical protocol: how patients are evaluated, how prescriptions are issued, how the program is supervised over time.
Once certified, the certification must be renewed annually and maintained in good standing. If a practice changes its prescribing structure, pharmacy partnership, or state footprint, LegitScript must be notified.
“From the Field: The practices that get burned by this are the ones that build out their landing pages, write their ad copy, and set up their campaigns, and then discover they can't run anything until they're certified. LegitScript is not optional for this category. It is the starting point. Plan for the certification timeline before you plan anything else.”
GLP-1 Google Ads Campaign Structure by Intent Level
Once LegitScript certification is in place, the campaign structure for GLP-1 Google Ads follows the same logic that applies across all healthcare specialties: segment by intent, not by budget convenience.
GLP-1 search queries cluster into three distinct intent levels, and each requires its own campaign.
Campaign 1: Medication-Specific Terms
Queries: "semaglutide prescription online," "tirzepatide for weight loss," "Ozempic online prescription," "Wegovy near me," "GLP-1 prescription telehealth."
These are the highest-intent queries in the category. The patient knows the medication by name and is actively looking for a provider who can prescribe it. Consultation-to-enrollment conversion rates are highest from this campaign because the patient has already identified the treatment they want.
Budget recommendation: 40 to 50 percent of total GLP-1 Google Ads budget. This is the highest-value traffic even if CPL is higher than the other campaigns.
Ad copy direction: emphasize the clinical program behind the prescription, not just the medication. "GLP-1 prescription with medical supervision and lifestyle coaching" differentiates from practices that are prescribing without ongoing monitoring, and it pre-qualifies patients who want a real program versus those who just want a prescription.
Landing page: medication-specific page that confirms the medications prescribed, the prescribing provider credentials, the clinical evaluation process, and the program structure. Not a generic weight loss page.
Campaign 2: Weight Loss Program Terms
Queries: "medical weight loss program," "weight loss clinic near me," "doctor supervised weight loss," "medical weight management," "weight loss prescription program."
These patients know they want medical weight loss but may not have identified GLP-1 medications specifically. CPL is typically lower than the medication campaign because the query is less specific. Consultation rate is also lower because some of these patients are still deciding between clinical and non-clinical approaches.
Budget recommendation: 30 to 40 percent of total budget. Strong volume, moderate intent.
Ad copy direction: lead with the clinical and supervised nature of the program. This is where the differentiation from DTC direct-mail programs and wellness chains matters, position the practice as the medically credentialed option.
Campaign 3: Telehealth Access Terms
Queries: "online weight loss doctor," "telehealth weight loss prescription," "GLP-1 online clinic," "[state] telehealth weight loss."
These patients are specifically looking for telehealth access, either because they are in a geography with limited in-person options or because they prefer remote care delivery. CPL is often lowest here because competition from other practices may be lower in specific states. Conversion rate varies by state.
Budget recommendation: 20 to 30 percent of total budget. Geographic targeting must match the states where the practice is licensed.
“How to act on it: Step 1: Confirm LegitScript certification status before building any campaign. Step 2: Map your state licensing footprint, this determines which geographies each campaign can target. Step 3: Build three separate campaigns as described above, each with its own budget and landing page. Step 4: Set geographic targeting in each campaign to match your licensed states only. Step 5: After 60 days of data, calculate consultation-to-enrollment rate by campaign and shift budget toward the campaign producing the best enrolled patients, not just the lowest CPL.”
Weight Loss Clinic Google Ads: CPL Benchmarks and What They Mean
GLP-1 and medical weight loss Google Ads CPL varies significantly by query type, market, and program structure. These benchmarks reflect Practice Growth Co campaign data across GLP-1 and medical weight loss clients.
| Campaign Type | CPL Range | Consult-to-Enroll Rate | Cost Per Enrolled Patient | Notes |
|---|---|---|---|---|
| Medication-specific (semaglutide, tirzepatide) | $55-$110 | 35-50% | $120-$300 | Highest intent, fastest conversion |
| Weight loss program (general medical) | $38-$78 | 25-40% | $100-$300 | Moderate intent, good volume |
| Telehealth access terms | $28-$65 | 30-45% | $65-$210 | State-dependent, lower competition |
| Brand / competitor terms | $18-$40 | 40-60% | $35-$95 | Defensive, limited volume |
Source: Practice Growth Co campaign data, 2025-2026. Ranges reflect LegitScript-certified accounts with service-specific landing pages. Non-certified accounts or accounts without condition-specific landing pages will see performance toward or above upper benchmarks.
The metric that matters in GLP-1 patient acquisition is cost per enrolled patient, not CPL. A $110 CPL from the medication-specific campaign with a 45 percent enrollment rate produces a $244 cost per enrolled patient. A $38 CPL from the weight loss program campaign with a 25 percent enrollment rate produces a $152 cost per enrolled patient. The lower CPL campaign produces better cost per enrolled patient in this scenario, but the answer flips if the medication campaign's enrollment rate is higher or the program campaign's rate drops.
Evaluate both sides of the equation before shifting budget. The campaign that appears more expensive on CPL may be producing more valuable patients.
GLP-1 Telehealth Advertising: Targeting Patients by State and Access Need
State-level targeting is the most important structural decision in GLP-1 telehealth Google Ads. A practice licensed in 12 states cannot run a single national campaign, it needs to target only the states where enrollment is legally permissible.
The practical implication: geographic targeting in Google Ads must be set at the campaign level to match the practice's exact state licensing footprint. Running a single "national" campaign and hoping patients in licensed states find you produces wasted spend in states where the practice cannot legally enroll them.
State-level considerations that affect GLP-1 Google Ads performance:
Market competition by state. Larger states with established telehealth infrastructure (California, Texas, Florida, New York) have significantly more competition and higher CPLs than smaller or mid-size states. A practice that can compete effectively in Wyoming or Idaho may find CPL 40 to 60 percent lower than the same campaign structure in Los Angeles or Miami.
Search volume by state. GLP-1 search volume correlates with state population but also with obesity prevalence and telehealth adoption. States with higher obesity rates and lower access to in-person bariatric care often have strong search volume relative to their population.
Insurance and coverage variation. State-level Medicaid and employer insurance GLP-1 coverage policies have been changing rapidly. Practices in states where GLP-1 coverage has expanded may find patients who are specifically searching for providers that accept their insurance, an underserved niche in paid search.
This connects to the full GLP-1 practice positioning strategy covered in the GLP-1 and medical weight loss marketing pillar. Telehealth targeting is one execution layer within a broader clinical differentiation strategy.
For the channel-level framework that applies across healthcare paid search, the Google Ads for healthcare practices pillar covers account structure, bidding, and conversion tracking in full.
FAQ: Google Ads Questions from GLP-1 and Weight Loss Practices
Do I need LegitScript certification to run Google Ads for my GLP-1 practice?
Yes. Google requires LegitScript certification for any practice advertising prescription medication programs, including GLP-1 drugs like semaglutide and tirzepatide. Without certification, Google will disapprove ads related to prescription weight loss medications. The certification process typically takes four to eight weeks. Apply before you plan your Google Ads launch date, not after.
Can I advertise compounded semaglutide on Google?
LegitScript applies additional scrutiny to compounded medication advertising and Google's policies in this area have tightened significantly since 2024. Practices advertising compounded GLP-1 medications should consult with LegitScript directly before assuming they can run compliant ads. FDA enforcement actions and supply chain restrictions on compounded GLP-1s have created a moving compliance target. Verify current policy before investing in campaign infrastructure.
What is a realistic budget for GLP-1 Google Ads?
A single-state telehealth practice targeting medication-specific and weight loss program terms needs $3,000 to $5,000 per month to generate meaningful lead volume. A multi-state practice running campaigns across five or more licensed states needs $8,000 to $18,000 or more per month. Under-budgeted campaigns generate insufficient conversion data and inconsistent delivery. GLP-1 is a competitive category in paid search, budget below the competitive threshold and the campaign will underperform regardless of how well it is built.
How do I prevent my GLP-1 Google Ads from targeting states where I am not licensed?
Set geographic targeting at the campaign level, not the ad group or account level. Use "Presence: People in or regularly in your targeted locations" to ensure targeting applies to where patients physically are, not just where they express interest. Exclude states where the practice is not licensed using the geographic exclusion feature. Review targeting settings after any Google Ads interface updates, as targeting defaults can shift during platform changes.
Why is my GLP-1 CPL higher than the benchmarks above?
Common causes: keyword match types that are too broad and capturing unqualified traffic (general weight loss content, diet app searches, nutrition queries); landing pages that are not specific to the medication or program the patient searched for; geographic targeting that is too wide and including high-competition markets without sufficient budget to compete; or ad copy that emphasizes the medication over the program, attracting price-shopping patients who will not enroll when they see the full cost of the program.
GLP-1 Google Ads done correctly starts with LegitScript certification, moves to intent-based campaign separation, and evaluates performance on cost per enrolled patient rather than cost per lead. Practice Growth Co builds and manages Google Ads accounts for GLP-1 and medical weight loss practices from compliance setup through campaign optimization. Book a Strategy Call →
Mike Funkhouser is the founder of Practice Growth Co, a healthcare-focused patient acquisition agency specializing in Google Ads, Meta Ads, SEO, and AI search optimization for specialty medical practices. He has helped plastic surgery groups, orthopedic clinics, med spas, and specialty practices build scalable, measurable patient acquisition systems across the US.
Sources and Citations
- LegitScript — Healthcare Merchant Certification — LegitScript certification requirements for prescription drug advertisers on Google
- Google Ads Help — Healthcare and Medicines Policy — Google policy documentation for healthcare and prescription medication advertising
- FDA — GLP-1 Compounded Drug Information — FDA guidance on semaglutide medications and compounded drug status
- Practice Growth Co — Google Ads Performance Data Across GLP-1 and Medical Weight Loss Clients — Proprietary Practice Growth Co campaign data, 2025-2026